Literature DB >> 28947073

Expanding the phenotype of SCA19/22: Parkinsonism, cognitive impairment and epilepsy.

Vincent Huin1, Isabelle Strubi-Vuillaume2, Kathy Dujardin3, Marine Brion4, Marie Delliaux4, Delphine Dellacherie5, Jean-Christophe Cuvellier5, Jean-Marie Cuisset5, Audrey Riquet5, Caroline Moreau3, Luc Defebvre3, Bernard Sablonnière6, David Devos7.   

Abstract

INTRODUCTION: Spinocerebellar ataxia types 19 and 22 (SCA19/22) are rare conditions in which relatively isolated cerebellar involvement is frequently associated with cognitive impairment. Here, we report on new clinical features and provide details of the cognitive profile in two SCA19/22 families.
METHODS: Two families displaying an autosomal-dominant form of cerebellar ataxia underwent clinical examinations and genetic testing.
RESULTS: In addition to the classical clinical features of SCA, a wide spectrum of cognitive disorders (including visuospatial impairments) was observed. Eight patients had mild Parkinsonism, and five had epilepsy. Genetic testing showed that the KCND3 mutation (c.679_681delTTC, p.F227del) was present in both families.
CONCLUSIONS: Our findings broaden the phenotypic spectrum of SCA19/22, and suggest that KCND3 should be included in the list of candidate genes for epilepsy, Parkinsonism and cognitive impairment.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cognitive disorders; Epilepsy; KCND3 mutation; Neurogenetics; Neuropsychiatric disorder; Parkinson's disease; Spinocerebellar ataxia

Mesh:

Year:  2017        PMID: 28947073     DOI: 10.1016/j.parkreldis.2017.09.014

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

1.  Genetic screening for potassium channel mutations in Japanese autosomal dominant spinocerebellar ataxia.

Authors:  Yui Tada; Kodai Kume; Yukiko Matsuda; Takashi Kurashige; Yuhei Kanaya; Ryosuke Ohsawa; Hiroyuki Morino; Hayato Tabu; Satoshi Kaneko; Toshihiko Suenaga; Akira Kakizuka; Hideshi Kawakami
Journal:  J Hum Genet       Date:  2020-01-07       Impact factor: 3.172

2.  Novel Features and Abnormal Pattern of Cerebral Glucose Metabolism in Spinocerebellar Ataxia 19.

Authors:  Martin Paucar; Åsa Bergendal; Peter Gustavsson; Magnus Nordenskjöld; José Laffita-Mesa; Irina Savitcheva; Per Svenningsson
Journal:  Cerebellum       Date:  2018-08       Impact factor: 3.847

Review 3.  KCND3-Related Neurological Disorders: From Old to Emerging Clinical Phenotypes.

Authors:  Luca Pollini; Serena Galosi; Manuela Tolve; Caterina Caputi; Carla Carducci; Antonio Angeloni; Vincenzo Leuzzi
Journal:  Int J Mol Sci       Date:  2020-08-13       Impact factor: 5.923

4.  V374A KCND3 Pathogenic Variant Associated With Paroxysmal Ataxia Exacerbations.

Authors:  Martin Paucar; Richard Ågren; Tianyi Li; Simon Lissmats; Åsa Bergendal; Jan Weinberg; Daniel Nilsson; Irina Savichetva; Kristoffer Sahlholm; Johanna Nilsson; Per Svenningsson
Journal:  Neurol Genet       Date:  2021-01-06

5.  Key Modules and Hub Genes Identified by Coexpression Network Analysis for Revealing Novel Biomarkers for Spina Bifida.

Authors:  Zijian Li; Juan Feng; Zhengwei Yuan
Journal:  Front Genet       Date:  2020-12-02       Impact factor: 4.599

Review 6.  Spinocerebellar ataxias (SCAs) caused by common mutations.

Authors:  Ulrich Müller
Journal:  Neurogenetics       Date:  2021-08-16       Impact factor: 2.660

7.  Rare KCND3 Loss-of-Function Mutation Associated With the SCA19/22.

Authors:  Mengjie Li; Fen Liu; Xiaoyan Hao; Yu Fan; Jiadi Li; Zhengwei Hu; Jingjing Shi; Liyuan Fan; Shuo Zhang; Dongrui Ma; Mengnan Guo; Yuming Xu; Changhe Shi
Journal:  Front Mol Neurosci       Date:  2022-06-23       Impact factor: 6.261

8.  Novel KCND3 Variant Underlying Nonprogressive Congenital Ataxia or SCA19/22 Disrupt KV4.3 Protein Expression and K+ Currents with Variable Effects on Channel Properties.

Authors:  Ginevra Zanni; Chen-Tsung Hsiao; Ssu-Ju Fu; Chih-Yung Tang; Alessandro Capuano; Luca Bosco; Federica Graziola; Emanuele Bellacchio; Serenella Servidei; Guido Primiano; Bing-Wen Soong; Chung-Jiuan Jeng
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.